Clinic for Rheumatology and Internal Medicine

Freiburg im Breisgau

0 studies enrolling now · 2 studies all time

What they study most

Lupus Erythematosus, Systemic

Studies at this site

• A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus — Completed
• Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus — Completed